Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma

Fig. 4

More tumorspheres were formed after RAD51 overexpression, however, no difference in expressions of stemness marker. Tumorsphere formation in (A) OECM1 EV (control) and (B) OECM1 RAD51 OE (overexpression) cells; (C) The bar chart describes the number of spheres formed in OECM1 EV and OECM1 RAD51 OE cells. More tumorspheres were formed in OECM1 RAD51 OE cells, (D) CD44 expression in OECM1 EV and OECM1 RAD51 OE cells, (E) CD133 expression in OECM1 EV and OECM1 RAD51 OE cells, (F) Nanog expression in OECM1 EV and OECM1 RAD51 OE cells, (G) Oct-4 expression in OECM1EV and OECM1 RAD51 OE cells, (H) SOX2 expression in OECM1 EV and OECM1 RAD51 OE cells, (I) RAD51 expression in OECM1 EV and OECM1 RAD51 OE cells

NS, not significant; *, P < 0.05

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us